Bio-G Bioproduction Group Company Profile

23:32 EDT 22nd March 2018 | BioPortfolio

Bio-G brings detailed industry knowledge to its focus on operations modeling for the Biotech sector. We build and deploy operations tools that drive day-to-day, tactical and strategic decision making for some of the world's largest biopharmaceutical manufacturers.

We have a detailed knowledge of biotech operations, bringing a wealth of tools and methodologies to spur operational change.

Bio-G's platform sets a new standard for operations analysis at a time when the key challenge is to move beyond data generation to knowledge creation.

Bio-G's Simulation System is an analysis environment designed for modeling complex biological processes.

The software integrates operations, tactical and strategic decision making into one powerful platform designed to drive systemic change across the organization. Linking to enterprise platforms, the Simulation System provides unprecedented visibility into the supply chain and the underlying processes which define it.


1250 Addison Street, Suite 107
United States of America


Phone: (510) 725 8952
Fax: (510) 704 0569

News Articles [321 Associated News Articles listed on BioPortfolio]

CHO‐omics Review: The Impact of Current and Emerging Technologies on Chinese Hamster Ovary Based Bioproduction

CHO cells are the most prevalent platform for modern bio‐therapeutic production. Currently, there are several CHO cell lines used in bioproduction with distinct characteristics and unique genotypes ...

BioProduction 2017 on the Green Isle: Live updates from Dublin


Evolution of Engineered Organisms Constrains Bioproduction

Organisms engineered to churn out valuable chemicals tend to slack off when they should be working most productively, after they’ve been introduced to large-scale fermentation vessels. But why? Some...

Horizon Discovery’s Bioproduction cell line used as part of a successful drug (IND) filing

Horizon’s Glutamine Synthetase-Knockout CHO K1 cell line has been used as part of a successful Investigational New Drug filing with the FDA Filing further validates the use of Horizo...

Abzena ups and integrates biomanufacturing and conjugation capabilities

Abzena has negotiated the lease on a 50,000 square foot site in San Diego as part of a $17m remodelling of its bioproduction and conjugation facilities.

Pausing evolution makes bioproduction of chemicals affordable and efficient

(Technical University of Denmark) Circumventing evolution in cell factories can pave the way for commercializing new biobased chemicals to large-scale.

Thermo Fisher suggests bio-researchers order before 2018 price hike:

Thermo Fisher will up its list prices by an average of 3.3% across much of its early-stage bioproduction product range, reflecting changing market conditions.

EMA approves production at Samsung Biologics 152,000L plant

The worldâs largest single bioproduction plant has received its first EU regulatory approval to make a monoclonal antibody, says CDMO Samsung Biologics.

PubMed Articles [1842 Associated PubMed Articles listed on BioPortfolio]

Transporter engineering in biomass utilization by yeast.

Biomass resources are attractive carbon sources for bioproduction because of their sustainability. Many studies have been performed using biomass resources to produce sugars as carbon sources for cell...

Transcanalicular laser-assisted dacryocystorhinostomy with diode laser.

This article compares the efficacy of transcanalicular laser assisted dacryocystorhinostomy (TL DCR) with conventional external dacryocystorhinostomy (Ex DCR). All patients were randomly divided into ...

Thirty first annual symposium on etiology, pathogenesis, and treatment of Parkinson disease and other movement disorders: Presented by the Parkinson study group, huntington study group, dystonia study group, tourette syndrome study group, cooperative ataxia group, and tremor research group.

Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis.

Medulloblastoma, the most common malignant pediatric brain tumor, is a heterogeneous disease, with the existence of at least four molecular types: Wingless (WNT), Sonic Hedgehog (SHH), Group 3 and Gro...

Application of the Pentafluorosulfanyl Group as a Bioisosteric Replacement.

The success of fluorinated molecules in drug design has led medicinal chemists to search for new fluorine-containing substituents. A major recently developed group is the pentafluorosulfanyl group. Th...

Clinical Trials [3533 Associated Clinical Trials listed on BioPortfolio]

The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies

The aim of the study was to evaluate the effects of hypotensive treatment combined with a higher zinc supply in the diet and supplements on the mineral status and selected biochemical para...

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

Electro-acupuncture and Flumazenil's Effect on Sedation

Object: To explore the mechanism of the electro-acupuncture (EA) induced sedation effect in general anaesthesia through investigating the role of the Benzodiazepines-GABA system. Method: ...

The Effect of Rhubarb on Sepsis and Post-traumatic Gastrointestinal Function Failure

Random grouping by computer, divided into two groups, a group of rhubarb treatment group, another group for the placebo group.

Companies [1606 Associated Companies listed on BioPortfolio]

BioSepra Incorporated

BioSepra's proprietary tools for the analysis, purification, and manufacturing of biomolecules - HyperDiffusionÆ chromatography media, large-scale production gels, lab-to-large scale columns - ad...

Bio-G Bioproduction Group

Bio-G brings detailed industry knowledge to its focus on operations modeling for the Biotech sector. We build and deploy operations tools that drive day-to-day, tactical and strategic decision making ...


3DM Inc. has commercialized a revolutionary family of synthetic peptide biomaterials, currently sold to the majority of pharmaceutical drug discovery groups and across life science research. 3DM’s ...

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

Selexis SA and TeneoBio, Inc.

Selexis SA is a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, providing unparalleled proprietary technology a...

More Information about "Bio-G Bioproduction Group" on BioPortfolio

We have published hundreds of Bio-G Bioproduction Group news stories on BioPortfolio along with dozens of Bio-G Bioproduction Group Clinical Trials and PubMed Articles about Bio-G Bioproduction Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bio-G Bioproduction Group Companies in our database. You can also find out about relevant Bio-G Bioproduction Group Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Corporate Database Quicklinks

Searches Linking to this Company Record